Visible Genetics shares jump 7%

Article Abstract:

Toronto, Ont.-based Visible Genetics Inc. expects to receive approval for a new HIV test kit from the U.S. Food and Drug Administration. Visible Genetics, which saw its share price soar, is developing a gene typing and sequencing system for HIV.

Product development, Sales, profits & dividends, Finance

---

Odyssey nears end for cancer researcher

Article Abstract:

Ann Arbor, Mich.-based Biotherapies Inc. has announced that it will apply for a US license to distribute its new breast cancer diagnostic kits. Biotherapies asserts that mammastatin therapy will transform breast cancer treatment.

United States, Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Cancer R&D, Cancer research, Breast cancer, BioTherapies Inc.

---

Biotech bets on AIDS treatment kit

Article Abstract:

Toronto-based Visible Genetics Inc. has emerged as a top genetics company with the introduction of the first genetic test kit designed to assist physicians with mixing drugs for AIDS patients.

Care and treatment, AIDS patients

Similar abstracts:

• Abstracts: Investors ignore eBay's solid earnings. Impotence treatment wins patent. E-retailers run low on fuel
• Abstracts: Impatient P&G ousts Jager. GE posts record profit; Welch sets retirement date. From emperor to outcast
• Abstracts: Airline pursue the trail of bucks. Charter flights being sold one seat at a time. Reagan National stretches west with new non-stops
• Abstracts: United mechanics' disputes spark FAA safety inquiry. Northwest on approach to labor peace
• Abstracts: TD appoints Clark to No. 2 job. Bloomberg quits National Bank unit. Two BMO veterans leave jobs in shuffle

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.